title: Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do.
authors.forename: Mark
authors.initials: M
authors.lastname: Sherlock
authors.forename: Andy A
authors.initials: AA
authors.lastname: Toogood
authors.forename: Richard
authors.initials: R
authors.lastname: Steeds
mesh_terms: D000077465:Cabergoline; D018491:Dopamine Agonists / Q000009:adverse effects*; D004452:Echocardiography; D004873:Ergolines / Q000009:adverse effects; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006351:Heart Valves / Q000187:drug effects; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy; D010479:Pergolide / Q000009:adverse effects; D014262:Tricuspid Valve Insufficiency / Q000139:chemically induced
chemical_list: D018491:Dopamine Agonists; D004873:Ergolines; D010479:Pergolide; D000077465:Cabergoline